Ophthalmology Drug And Device Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Ophthalmology Drug and Device Market are Segmented by Product (devices and Drugs), Disease (Glaucoma, Cataract, Age-Related Macular Degeneration, Inflammatory Diseases, Refractive Disorders, and Other Diseases), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value in ( USD Million) for the Abovementioned Segments.

Ophthalmology Drug And Device Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Ophthalmology Drug & Device Market Size

Ophthalmology Drug And Device Market (2024 - 2029)
Study Period 2019 - 2030
Base Year For Estimation 2024
Market Size (2025) USD 92.14 Billion
Market Size (2030) USD 120.25 Billion
CAGR (2025 - 2030) 5.47 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Ophthalmology Drug and Device Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Ophthalmology Drug And Device Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Ophthalmology Drug & Device Market Analysis

The Ophthalmology Drug And Device Market size is estimated at USD 92.14 billion in 2025, and is expected to reach USD 120.25 billion by 2030, at a CAGR of 5.47% during the forecast period (2025-2030).

The COVID-19 pandemic had a significant impact on the market initially as several countries were in lockdown, and trades were suspended with other countries with travel restrictions, leading to a decline in eye diagnoses. As a cautionary measure, many ophthalmologists temporarily closed their practices during the pandemic. According to an article published by the Indian Journal of Ophthalmology in December 2021, a survey was conducted among the All India Ophthalmological Society (AIOS) members, which stated that COVID-19 had adversely affected ophthalmic care services across the whole of India. As the number of COVID-19 cases has decreased significantly, the market has recovered and started to gain traction. Hence, the market is expected to have stable growth during the forecast period of the study.

Certain factors driving the market's growth include the impact of the prevalence of eye disease, demographic shift, technological advancements in the field of ophthalmology, and the rising geriatric population. According to the data updated by WHO in October 2022, it is estimated at least 2.2 billion people will have a near or distant vision impairment globally. Among these, at least 1 billion people's vision impairment could have been prevented or yet to get addressed. These 1 billion people include those with moderate or severe distance vision impairment or blindness due to various diseases like unaddressed refractive error (88.4 million), cataract (94 million), age-related macular degeneration (8 million), glaucoma (7.7 million), diabetic retinopathy (3.9 million), as well as near vision impairment caused by unaddressed presbyopia (826 million). In many countries, cataract surgery is the most common surgical procedure performed, significantly improving the quality of life of the elderly population at low costs. An increase in the elderly population and the high prevalence of ophthalmic disorders increases the demand for ophthalmological devices and projects the future cataract surgery needs vital for human health resources, hospitals, and surgical centre management and planning. Other factors, such as the availability of new devices and new drugs and the growing incidence of eye disease, are also expected to drive the market over the forecast period.

In addition, new product launches and strategic activities by major players in the market are positively affecting the growth of the studied market. For example, in June 2022, Biogen Inc. and Samsung Bioepis Co., Ltd. launched ranibizumab-nuna (Byooviz, Biogen), an ophthalmic biosimilar referencing ranibizumab (Lucentis, Genentech) in the US. Thus, due to the product launches and partnerships, the studied market is expected to grow significantly over the forecast period.

Therefore, owing to the factors above, the studied market is anticipated to witness growth over the analysis period. However, the higher cost of ophthalmic devices and treatment and strict FDA guidelines for drug approval is likely to impede the market's growth.

Ophthalmology Drug & Device Industry Overview

The ophthalmology drug and device market are moderately fragmented in nature. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known. It consists of major players such as Alcon Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, Essilor International SA, Haag-Streit Group (Metall Zug AG), Johnson & Johnson, Nidek Co. Ltd, Topcon Corporation, Ziemer Group AG, among others.

Ophthalmology Drug & Device Market Leaders

  1. Alcon Inc.

  2. Bausch Health Companies Inc.

  3. Carl Zeiss Meditec AG

  4. Johnson & Johnson

  5. Topcon Corporation

  6. *Disclaimer: Major Players sorted in no particular order
Ophthalmology Drug And Device Market
Need More Details on Market Players and Competiters?
Download PDF

Ophthalmology Drug & Device Market News

  • October 2022: Remidio launched Instaref R20, a lightweight and portable ophthalmic auto refractometer at the American Academy of Ophthalmology in Chicago.
  • September 2022: Santen and UBE announced that the FDA has approved Omlonti (omidenepag isopropyl ophthalmic solution) 0.002% eye drops. It reduces elevated intraocular pressure in patients with primary open-angle glaucoma or ocular hypertension.

Ophthalmology Drug And Device Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Demographic Shift and Impact of Prevalence of Eye Disease
    • 4.2.2 Technological Advancements in the Field of Ophthalmology
  • 4.3 Market Restraints
    • 4.3.1 Higher Cost of the Ophthalmic Devices and Treatment
    • 4.3.2 Strict FDA Guidelines for Drug Approval
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Devices
    • 5.1.1.1 Surgical Devices
    • 5.1.1.1.1 Intraocular Lenses
    • 5.1.1.1.2 Ophthalmic Lasers
    • 5.1.1.1.3 Other Surgical Devices
    • 5.1.1.2 Diagnostic Devices
    • 5.1.2 Drugs
    • 5.1.2.1 Glaucoma Drugs
    • 5.1.2.2 Retinal Disorder Drugs
    • 5.1.2.3 Dry Eye Drugs
    • 5.1.2.4 Allergic Conjunctivitis and Inflammation Drugs
    • 5.1.2.5 Other Drugs
  • 5.2 By Disease
    • 5.2.1 Glaucoma
    • 5.2.2 Cataract
    • 5.2.3 Age-Related Macular Degeneration
    • 5.2.4 Inflammatory Diseases
    • 5.2.5 Refractive Disorders
    • 5.2.6 Other Diseases
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Alcon Inc.
    • 6.1.2 Bausch Health Companies Inc.
    • 6.1.3 Carl Zeiss Meditec AG
    • 6.1.4 Essilor International SA
    • 6.1.5 Haag-Streit Group (Metall Zug AG)
    • 6.1.6 Johnson & Johnson
    • 6.1.7 Nidek Co. Ltd
    • 6.1.8 Topcon Corporation
    • 6.1.9 NIDEK Co. Ltd
    • 6.1.10 Lumenis Ltd
    • 6.1.11 Ziemer Ophthalmic Systems AG
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Ophthalmology Drug & Device Industry Segmentation

As per the scope of the report, ophthalmology drug and device includes all the products that ophthalmologists use to diagnose, treat, and care for the eyes. The Ophthalmology Drug and Device Market are segmented by product (devices and drugs), disease (Glaucoma, Cataract, age-related macular degeneration, inflammatory diseases, refractive disorders, and other diseases), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value in ( USD million) for the abovementioned segments.

By Product Devices Surgical Devices Intraocular Lenses
Ophthalmic Lasers
Other Surgical Devices
Diagnostic Devices
Drugs Glaucoma Drugs
Retinal Disorder Drugs
Dry Eye Drugs
Allergic Conjunctivitis and Inflammation Drugs
Other Drugs
By Disease Glaucoma
Cataract
Age-Related Macular Degeneration
Inflammatory Diseases
Refractive Disorders
Other Diseases
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Ophthalmology Drug And Device Market Research Faqs

How big is the Ophthalmology Drug And Device Market?

The Ophthalmology Drug And Device Market size is expected to reach USD 92.14 billion in 2025 and grow at a CAGR of 5.47% to reach USD 120.25 billion by 2030.

What is the current Ophthalmology Drug And Device Market size?

In 2025, the Ophthalmology Drug And Device Market size is expected to reach USD 92.14 billion.

Which is the fastest growing region in Ophthalmology Drug And Device Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Ophthalmology Drug And Device Market?

In 2025, the North America accounts for the largest market share in Ophthalmology Drug And Device Market.

What years does this Ophthalmology Drug And Device Market cover, and what was the market size in 2024?

In 2024, the Ophthalmology Drug And Device Market size was estimated at USD 87.10 billion. The report covers the Ophthalmology Drug And Device Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Ophthalmology Drug And Device Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Ophthalmology Drug And Device Industry Report

Statistics for the 2025 Ophthalmology Drug And Device market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Ophthalmology Drug And Device analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.